Considering findings from both study periods together, although the majority of NP-C patients with two NPC1 mutations had elevated levels of both ChT and CCL18/PARC, two subjects had a clear genetic diagnosis of NP-C but showed raised levels of only one of these biomarkers. Here, CCL18 is linked to nasopharyngeal carcinoma.